文献速递膀胱癌与上尿路尿路上皮癌

长链非编码RNA UCA1原位杂交检测尿液中高级别膀胱癌

Detection of High-grade Bladder Cancer in Urine Samples Using In Situ Hybridization of Long Noncoding RNA UCA1.
PubMed 文献 · Urology · 2025-05-13

本研究评估尿液生物标志物长链非编码RNA UCA1通过RNA原位杂交(RISH)检测高级别膀胱癌的性能。在50例确诊膀胱癌患者中,尿液细胞学检测高级别膀胱癌的敏感性为34.4%,NPV为36.4%;RISH敏感性为66.7%,NPV为50%;细胞学序贯RISH的敏感性为78.1%,NPV为53.3%。UCA1可提高尿液细胞学单独检测高级别膀胱癌的敏感性和NPV。

要点

  • UCA1在膀胱癌组织中较正常对照显著上调。
  • RISH检测高级别膀胱癌敏感性66.7%,高于细胞学的34.4%。
  • 细胞学序贯RISH可将敏感性提升至78.1%。

核心结论

  • UCA1可提高尿液细胞学单独检测高级别膀胱癌的敏感性和阴性预测值。

研究设计与样本

  • 利用TCGA和Cancer Cell Line Encyclopedia数据库分析UCA1表达模式,并开发细胞学涂片UCA1 RISH检测方法。
  • 收集接受经尿道膀胱肿瘤电切术或根治性膀胱切除术患者的尿液和病理样本,比较RISH与细胞学检测高级别膀胱癌的性能。
  • 在50例确诊膀胱癌患者中计算RISH单独、细胞学单独及细胞学序贯RISH的敏感性、特异性、阳性预测值和阴性预测值。

主要发现

  • UCA1在膀胱癌组织中较正常对照显著上调。
  • 在50例确诊膀胱癌患者中,尿液细胞学检测高级别膀胱癌的敏感性为34.4%,NPV为36.4%。
  • RISH检测高级别膀胱癌的敏感性为66.7%,NPV为50%。
  • 细胞学序贯RISH检测高级别膀胱癌的敏感性为78.1%,NPV为53.3%。

临床怎么用

  • UCA1 RISH可作为尿液细胞学的补充,用于高级别膀胱癌的筛查和监测。

局限性

  • 本研究为初步研究(pilot study),样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of urinary biomarker long noncoding RNA urothelial carcinoma-associated 1 (UCA1) in detection of high-grade bladder cancer (BCa) using RNA in situ hybridization (RISH). Urine cytology and cystoscopy are the gold standard for BCa detection. There is a paucity of reliable urinary biomarkers for BCa detection in clinical practice. METHODS: TCGA and Cancer Cell Line Encyclopedia databases were utilized to analyze the expression pattern of UCA1 in BCa surgical specimens and cell lines. A method for detection of UCA1 expression on cytology slides was developed. Urine and pathology samples were collected from patients undergoing trans-urethral resection of bladder tumor or radical cystectomy. Performance of RISH and cytology were evaluated for detection of high-grade BCa, vs low-grade and no BCa. The sensitivity, specificity, positive predictive value, negative predictive value (NPV) of RISH alone, cytology alone, and sequential use of cytology followed by RISH in cases of atypical or negative cytology were calculated. RESULTS: UCA1 was significantly upregulated in BCa tissues compared to normal controls. In 50 patients with a confirmed diagnosis of BCa, urine cytology had a sensitivity 34.4%, NPV 36.4% for detection of high grade BCa. RISH had a sensitivity 66.7%, NPV 50%. Sequential testing including both cytology and RISH revealed a sensitivity 78.1%, NPV 53.3%. CONCLUSION: UCA1 improves sensitivity and NPV of urine cytology alone for detection of high grade BCa. This pilot study demonstrates potential utility of UCA1 as a urinary biomarker to augment cytology for screening and surveillance of high grade BCa.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Higgins MI, Li J, Ahmed W, et al. Detection of High-grade Bladder Cancer in Urine Samples Using In Situ Hybridization of Long Noncoding RNA UCA1. Urology. 2025. PMID: 40374004. doi:10.1016/j.urology.2025.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。